Actos

Type: Product
Name: Actos
First reported 10 hours ago - Updated 10 hours ago - 1 reports

The ghosts of litigation holds past

Earlier this year, in the widely followed In re: Actos (Pioglitazone) Products Liability Litigation matter, a Louisiana federal jury ordered a drug manufacturer to pay $6 billion in punitive damages and $1.5 million in actual damages.1 An adverse ruling ... [Published Lexology - 10 hours ago]
First reported Jul 27 2014 - Updated Jul 27 2014 - 1 reports

Hi Newbie

I was diagnosis with PCOS years ago. I was taking Actos and other birth control pills. I stop them a long time ago. Now I recent stop taking Depo Provera shot. I don't get my periods anymore. But I'm getting sick and tired of the hair on my chin ... [Published HealthBoards - Jul 27 2014]
First reported Jul 25 2014 - Updated Jul 25 2014 - 1 reports

The Ghosts of Litigation Holds Past

Earlier this year, in the widely followed In re: Actos (Pioglitazone) Products Liability Litigation matter, a Louisiana federal jury ordered a drug manufacturer to pay $6 billion in punitive damages and $1.5 million in actual damages. An adverse ruling ... [Published JD Supra - Jul 25 2014]
Entities: Litigation, Actos, PDF
First reported Jul 23 2014 - Updated Jul 24 2014 - 1 reports

Diabetes drug Actos associated with lower rates of Alzheimers disease

A study of over 100,000 people from German healthcare records show the drug, pioglitazone, to be linked with lower rates of Alzheimer's disease.Actos is in a class of drugs called thiazolidinediones, or TZDs for short. These drugs work by increasing the ... [Published Diabetes.co.uk - Jul 23 2014]
First reported Jul 19 2014 - Updated Jul 19 2014 - 1 reports

A single protein jab to regulate diabetes: Study

Singapore: In a new breakthrough, scientists at the Salk's Gene Expression Laboratory have discovered a protein FGF1 that could reverse insulin insensitivity and the damage caused by diabetes.The study published in the journal Nature, found that a single ... [Published Bio Spectrum Asia - Jul 19 2014]
First reported Jul 18 2014 - Updated Jul 18 2014 - 1 reports

Database provides fresh evidence of effect of diabetes drugs on Alzheimer's

While clinical trials remain the gold standard for proving safety and efficacy, the scale, real-world mix of patients and relatively low costs associated with database-powered studies make them a useful option for researchers. This week a German team ... [Published Fierce Biotech IT - Jul 18 2014]
First reported Jul 15 2014 - Updated Jul 16 2014 - 1 reports

Diabetes medication could reduce risk of developing dementia according to study

Large scale research into a database of patients in Germany has indicated that some diabetes medication seems to reduce the risk of developing Alzheimer's disease .The fairly affordable drug in question, pioglitazone , is commonly used to treat type 2 ... [Published Diabetes.co.uk - Jul 15 2014]
First reported Jul 15 2014 - Updated Jul 15 2014 - 1 reports

Morning Break: Smart Lenses, 'I'm Not Dead!'

OphthalmologyPublished: Jul 15, 2014By MedPage Today StaffNovartis said its Alcon division would use Google technology to develop a "smart" contact lens that could monitor glucose levels while correcting presbyopia.The firm also announced that it would ... [Published MedPage Today - Jul 15 2014]
First reported Jul 14 2014 - Updated Jul 15 2014 - 3 reports

Risk of Alzheimer's Could be Reduced by Simple Diabetes Drug, Says German Study

A team of German scientists might have found a drug that prevents Alzheimer's disease. [Picture representation]. Dvortygirl/FlickrGeneric medicines for diabetes, which is easily available, could prevent a person from having Alzheimer's later on in life, ... [Published International Business Times India - Jul 14 2014]
First reported Jul 01 2014 - Updated Jul 02 2014 - 1 reports

Takeda's Weber faces tough start

TOKYO -- Christophe Weber, new president of Japanese drugmaker Takeda Pharmaceutical, is tasked with solving a barrage of problems his company faces. The company's profitability is weighed down by its mainstay drugs losing patent protection. Also, it ... [Published Nikkei Asian Review - Jul 01 2014]
First reported Jun 30 2014 - Updated Jun 30 2014 - 1 reports

Mealey's PI/Product Liability - Takeda Seeks New Trial, JNOV In Actos Cancer Case, Wants Punitive Award Cut

LAFAYETTE, La. - Saying a $9 billion Actos bladder cancer punitive damage verdict is unconstitutional and excessive, Takeda Pharmaceutical Co. Ltd. on June 27 ask a multidistrict litigation court for a new trial, for judgment notwithstanding verdict (JNOV) ... [Published Mealey - Jun 30 2014]
First reported Jun 29 2014 - Updated Jun 29 2014 - 1 reports

Actos Lawsuit News: Federal Judge Overseeing Actos Bladder Cancer Litigation Finds Takeda Intentionally Destroyed Evidence

The federal judge overseeing thousands of Actos lawsuits (http://www.theactoslawsuitcenter.com/) in the U.S. District Court, Western District of Louisiana has ruled that Takeda Pharmaceuticals intentionally destroyed documents relevant to a bladder cancer ... [Published Digital Journal - Jun 29 2014]

Quotes

"It is important to note that this is not a clinical trial, so the data, while intriguing, are not so relevant to the clinic at this point" Keith Fargo, PhD, a director of medical and scientific relations at the Alzheimer's Association, told Medscape Medical News
Mr Ronald M Evans, director of Salk's Gene Expression Laboratory said, "Controlling glucose was a dominant problem in the society and FGF1 offered a new method to control glucose in a powerful and unexpected way."
...Diseases concluded that long-term Actos use cuts the risk of dementia, but others have questioned the real-world significance of the results. "It's actually almost surprising to me that the lowering of relative risk was so weak" Boston University professor Ben Wolozin told Bloomberg...
"Controlling glucose is a dominant problem in our society. And FGF1 offers a new method to"

More Content

All (166) | News (131) | Reports (0) | Blogs (32) | Audio/Video (0) | Fact Sheets (1) | Press Releases (2)
sort by: Date | Relevance
The ghosts of litigation holds past [Published Lexology - 10 hours ago]
Hi Newbie [Published HealthBoards - Jul 27 2014]
The Ghosts of Litigation Holds Past [Published JD Supra - Jul 25 2014]
Diabetes Drug Linked to Lower Dementia Risk [Published American Journal of Public Health - Jul 24 2014]
People with more brown fat better able to contr... [Published Diabetes.co.uk - Jul 24 2014]
Diabetes drug Actos associated with lower rates... [Published Diabetes.co.uk - Jul 23 2014]
Single Injection To Regulate Diabetes, Coming Soon [Published Peace FM - Jul 22 2014]
5 More Possible Partners For MannKind's Afrezza... [Published Seeking Alpha - Jul 21 2014]
Can one simple injection cure diabetes? [Published GMA News Online - Jul 21 2014]
A single protein jab to regulate diabetes: Study [Published Bio Spectrum Asia - Jul 19 2014]
Database provides fresh evidence of effect of d... [Published Fierce Biotech IT - Jul 18 2014]
Single injection normalizes glucose levels in t... [Published Medical News Today - Jul 18 2014]
U.K. gov names ex-biotech VC as life sci chief,... [Published FierceBiotech - Jul 18 2014]
Soon, single jab will be enough to regulate dia... [Published TruthDive - Jul 17 2014]
Protein jab gives hope in diabetes fight [Published Geelong Advertiser - Jul 16 2014]
Type 2 Diabetes Symptoms Reversed In Mice With ... [Published Medical Daily - Jul 16 2014]
One injection stops type 2 diabetes in its trac... [Published Medical Xpress - Jul 16 2014]
Protein jab hope in diabetes fight [Published Jersey Evening Post - Jul 16 2014]
Diabetes medication could reduce risk of develo... [Published Diabetes.co.uk - Jul 15 2014]
Morning Break: Smart Lenses, 'I'm Not Dead!' [Published MedPage Today - Jul 15 2014]
New Alzheimer's tests look at sights and smells [Published My Sun Coast - Jul 14 2014]
Study links Actos with delayed dementia [Published Medical Marketing And Media - Jul 14 2014]
Lilly's Cyramza misses liver-cancer target [Published Medical Marketing And Media - Jul 14 2014]
Abbott pairs generics with tax benefit [Published Medical Marketing And Media - Jul 14 2014]
Diabetes Drug Pioglitazone May Lower Risk of Al... [Published P&T Community - Jul 14 2014]
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Jul 14 2014]
Risk of Alzheimer's Could be Reduced by Simple ... [Published International Business Times India - Jul 14 2014]
Diabetic drug Actos may also act to stave off A... [Published Examiner.com - Jul 14 2014]
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Jul 14 2014]
German database study hints diabetes drug cuts ... [Published Reuters - Jul 14 2014]
1 2 3 4 5 6
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Hi Newbie [Published HealthBoards - Jul 27 2014]
I was diagnosis with PCOS years ago. I was taking Actos and other birth control pills. I stop them a long time ago. Now I recent stop taking Depo Provera shot. I don't get my periods anymore. But I'm getting sick and tired of the hair on my chin ...
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Jul 14 2014]
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Jul 14 2014]
Actos -- Another Motion for Sanctions [Published Drug and Device Law - Jun 24 2014]
br />!--[if gte mso 10]> /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; ...
Legal-Bay Lawsuit Settlement Funding Reports $9... [Published PR Newswire: Financial Services - Jun 19 2014]
NEW ORLEANS, June 19, 2014 /PRNewswire/ -- Legal-Bay LLC, the Lawsuit Settlement Funding Company, disclosed today a new-implemented program involving lawsuit cash advances for clients facing complications due to risky Actos prescription drugs. In ...
1 2 3 4 5 6 7

Press Releases

sort by: Date | Relevance
Fitch: Lilly's Ratings Intact Following $9B Act... [Published Fitch Ratings Headlines Corporate - Apr 08 2014]
Opening Statements Begin in Billion Dollar Acto... [Published Financial Services - Mar 06 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.